Mark Wigger
Overview
Explore the profile of Mark Wigger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasrija C, Debose-Scarlett A, Ragheb D, Siddiqi H, Amancherla K, Brinkley D, et al.
Ann Thorac Surg
. 2024 Dec;
PMID: 39730110
Background: Predicted heart mass (PHM) ratio has become the standard donor-recipient size matching method in heart transplantation. Although use of small PHM ratio hearts is associated with increased 1-year mortality,...
2.
Nandkeolyar S, Gupta T, Brinkley D, Alexopoulos S, Firsich E, Fossey S, et al.
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
15:100504.
PMID: 39713488
Introduction: Each year the number of combined heart-liver transplants (HLT) increases, with two distinct patient populations proceeding down this pathway. The first are patients with congenital heart disease (CHD), most...
3.
Amancherla K, Feurer I, Rega S, Cluckey A, Salih M, Davis J, et al.
J Card Fail
. 2023 Oct;
30(5):694-700.
PMID: 37907147
Background: Transplantation of hearts from hepatitis C virus (HCV)-positive donors has increased substantially in recent years following development of highly effective direct-acting antiviral therapies for treatment and cure of HCV....
4.
Siddiqi H, Trahanas J, Xu M, Wells Q, Farber-Eger E, Pasrija C, et al.
J Am Coll Cardiol
. 2023 Oct;
82(15):1512-1520.
PMID: 37793748
Background: Heart transplantation using donation after circulatory death (DCD) allografts is increasingly common, expanding the donor pool and reducing transplant wait times. However, data remain limited on clinical outcomes. Objectives:...
5.
Rali A, Ranka S, Butcher A, Shah Z, Tonna J, Anders M, et al.
JACC Heart Fail
. 2022 Jun;
10(6):397-403.
PMID: 35654524
Background: As utilization of veno-arterial extracorporeal life support (VA-ECLS) in treatment of cardiogenic shock (CS) continues to expand, clinical variables that guide clinicians in early recognition of myocardial recovery and...
6.
Rali A, Ranka S, Mazurek J, Brinkley M, Cedars A, Clark D, et al.
J Card Fail
. 2021 Oct;
28(3):415-421.
PMID: 34670174
Adults with congenital heart diseases may not be candidates for conventional therapies to control ventricular systolic dysfunction, including mechanical circulatory support, which moves potential heart-transplantation recipients to a listing status...
7.
Hoffman J, McMaster W, Rali A, Rahaman Z, Balsara K, Absi T, et al.
J Heart Lung Transplant
. 2021 Aug;
40(11):1408-1418.
PMID: 34334301
Background: Given the shortage of suitable donor hearts for cardiac transplantation and the growing interest in donation after circulatory death (DCD), our institution recently began procuring cardiac allografts from DCD...
8.
Balsara K, Rahaman Z, Sandhaus E, Hoffman J, Zalawadiya S, McMaster W, et al.
J Card Surg
. 2021 Jun;
36(9):3217-3221.
PMID: 34137079
Background: Coronavirus disease 2019 (COVID-19) has significantly impacted the healthcare landscape in the United States in a variety of ways including a nation-wide reduction in operative volume. The impact of...
9.
Schlendorf K, Zalawadiya S, Shah A, Perri R, Wigger M, Brinkley D, et al.
JAMA Cardiol
. 2019 Dec;
5(2):167-174.
PMID: 31851352
Importance: For patients awaiting heart transplant, hepatitis C-positive donors offer an opportunity to expand the donor pool, shorten wait times, and decrease wait-list mortality. While early reported outcomes among few...
10.
Zalawadiya S, Lindenfeld J, Shah A, Wigger M, Danter M, Brinkley D, et al.
ASAIO J
. 2019 Aug;
66(5):553-558.
PMID: 31425256
Donor-derived hepatitis C (dd-HCV) infection may increase the risk of renal impairment (RI) among heart transplantation (HT) recipients. Sofosbuvir, an integral component of HCV direct-acting antivirals (DAAs) has also been...